Palak Trivedi
Cited by
Cited by
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
WJ Lammers, HR Van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ...
Gastroenterology 147 (6), 1338-1349. e5, 2014
Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy
WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ...
Gastroenterology 149 (7), 1804-1812. e4, 2015
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ...
Gastroenterology 152 (8), 1975-1984. e8, 2017
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
PJ Trivedi, WJ Lammers, HR Van Buuren, A Parés, A Floreani, ...
Gut 65 (2), 321-329, 2016
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical …
European Society of Gastrointestinal Endoscopy, ...
Journal of hepatology 66 (6), 1265-1281, 2017
overlap syndromes and autoimmune liver disease
PJ Trivedi, GM Hirschfield
Alimentary pharmacology & therapeutics 36 (6), 517-533, 2012
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
P Fickert, GM Hirschfield, G Denk, HU Marschall, I Altorjay, M Färkkilä, ...
Journal of hepatology 67 (3), 549-558, 2017
Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response
PJ Trivedi, T Bruns, A Cheung, KK Li, C Kittler, T Kumagi, H Shah, ...
Journal of hepatology 60 (6), 1249-1258, 2014
Mucosal immunity in liver autoimmunity: a comprehensive review
PJ Trivedi, DH Adams
Journal of autoimmunity 46, 97-111, 2013
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo
JA Fallowfield, AL Hayden, VK Snowdon, RL Aucott, BM Stutchfield, ...
Hepatology 59 (4), 1492-1504, 2014
Indications, stains and techniques in chromoendoscopy
PJ Trivedi, B Braden
QJM: An International Journal of Medicine 106 (2), 117-131, 2013
The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
MN Quraishi, M Sergeant, G Kay, T Iqbal, J Chan, C Constantinidou, ...
Gut 66 (2), 386-388, 2017
Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis
E Liaskou, LE Jeffery, PJ Trivedi, GM Reynolds, S Suresh, T Bruns, ...
Gastroenterology 147 (1), 221-232. e7, 2014
PSC, AIH and overlap syndrome in inflammatory bowel disease
PJ Trivedi, RW Chapman
Clinics and research in hepatology and gastroenterology 36 (5), 420-436, 2012
Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists
PJ Trivedi, C Corpechot, A Pares, GM Hirschfield
Hepatology 63 (2), 644-659, 2016
Treatment of autoimmune liver disease: current and future therapeutic options
PJ Trivedi, GM Hirschfield
Therapeutic advances in chronic disease 4 (3), 119-141, 2013
Good maternal and fetal outcomes for pregnant women with primary biliary cirrhosis
PJ Trivedi, T Kumagi, N Al-Harthy, C Coltescu, S Ward, A Cheung, ...
Clinical Gastroenterology and Hepatology 12 (7), 1179-1185. e1, 2014
Obeticholic acid for the treatment of primary biliary cirrhosis
PJ Trivedi, GM Hirschfield, ME Gershwin
Expert review of clinical pharmacology 9 (1), 13-26, 2016
Gut–liver immunity
PJ Trivedi, DH Adams
Journal of Hepatology 64 (5), 1187-1189, 2016
Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity
PJ Trivedi, T Bruns, S Ward, M Mai, C Schmidt, GM Hirschfield, CJ Weston, ...
Journal of autoimmunity 68, 98-104, 2016
The system can't perform the operation now. Try again later.
Articles 1–20